Egens Biotechnology

Egens Biotechnology is a leading Chinese in-vitro diagnostics (IVD) company specializing in the research, development, and manufacturing of rapid diagnostic kits and reagents. Founded in 2002 and headquartered in Beijing, the company focuses on multiple testing platforms, including colloidal gold-based rapid tests, enzyme-linked immunosorbent assays (ELISA), and fluorescence immunoassays. Their product portfolio covers a wide range of medical fields such as infectious disease screening, oncology markers, cardiac markers, and drugs of abuse testing. Egens has established a significant international presence, exporting its diagnostic solutions to dozens of countries worldwide. The company operates high-standard manufacturing facilities and maintains extensive quality certifications to support its global commercial operations.